what is a glp-1 agonist Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Receptor Agonists: Scoping Review GLP-1 Medications: Everything You Need

[DOI] [PMC free article] [PubMed] [Google Scholar] 27.Capuccio S, Scilletta S, La Rocca F, Miano N, Di Marco M, Bosco G, Di Giacomo Barbagallo F, Scicali R, Piro S, Di Pino A

P.RuizL.FolgueiraC.RadaP.Gomez-SantosB.SolasM.et al (2024)

Marso SP, Daniels GH, BrownFrandsen K, et al

The majority, 57 percent, said that they think the future of GLP-1RA research is in metabolic syndrome

On average, volunteers in the retatrutide clinical trial who received the study drug rather than a placebo lost an average of 70.3 pounds over about a year-and-a-half, with more than 45% of participants losing more than 30% of their body weight

Through the LCT program, Wyse and his team annually evaluate dossier submissions to identify promising candidates for clinical trials, spanning the United States, Australia, the United Kingdom, and mainland Europe